TABS-Research

 

WHO Global Leprosy Update 2020

The Global leprosy (Hansen disease) update 2020, Impact of COVID-19 on global leprosy control, was published by the World Health Organization on 10 September 2021.

Download
 

PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention

BMJ Open published the PEP4LEP study protocol. It is titled, “PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention: comparing the effectiveness and feasibility of a community-based intervention to a health centre-based intervention in Ethiopia, Mozambique and … More PEP4LEP study protocol: integrated skin screening and SDR-PEP administration for leprosy prevention

Download
 

Safety in administering medicines for neglected tropical diseases

This WHO manual provides practical tools to help national programmes for neglected tropical diseases (NTDs) plan, prepare, and monitor the safe administration of medicines for the treatment of these diseases.

Visit
Updated: 13/08/2021
 

Global Leprosy (Hansen’s disease) Strategy 2021 – 2030

The World Health Organization’s Global Leprosy Strategy 2021 – 2030, “Toward Zero Leprosy,” outlines global targets for 2030 and includes 4 strategic pillars.

Visit
 

Leprosy/Hansen Disease: Management of reactions and prevention of disabilities

The WHO Global Leprosy Programme has re-released a report with additional information on the use of thalidomide for the treatment of ENL reactions. The guidance supports the use of thalidomide as a ‘steroid-sparing’ medication for ENL.

Visit
 

Chronic Care for Neglected Infectious Diseases

A new publication from the Pan American Health Organization (PAHO) focuses on DMDI (disease management, disability and inclusion) for four NTDs: leprosy, lymphatic filariasis, trachoma, and Chagas disease.

Visit
 

A Comprehensive Research Agenda for Zero Leprosy

The Zero Leprosy Research Agenda was published in Infectious Diseases of Poverty. 

Visit
 

Nitrosamine concerns for rifapentine and rifampicin: Update and FAQs

Update and FAQs from the World Health Organization on recent concerns for rifapentine and rifampicin

Download
 

ILEP Technical Commission 2020 Nomination Form

The ILEP Technical Commission and the ILEP Advisory Panel, which consists of women and men affected by leprosy, both come up for re-appointment in October. The appointments will be made by the ILEP Members’ Assembly, and we are now inviting … More ILEP Technical Commission 2020 Nomination Form

Download
 

Technical guidance on Reaction Management and Disability Prevention

Technical guidance from the WHO on the management of reactions and prevention of leprosy-related disability.

Download
 

Frequently Asked Questions About SDR-PEP

Frequently Asked Questions about SDR-PEP

Download
 

Research Report: Diagnostics

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on diagnostics here.

Download
 

Research Report: Vaccines

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on vaccines here.

Download
 

Research Report: Stigma

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on stigma here.

Download
 

Research Report: Operational Research

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on operational research here.

Download
 

Research Report: Epidemiologic Modeling

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on epdemiologic modeling here.

Download
 

Research Report: Disability

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on disability here.

Download
 

Research Report: Digital Health

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on digital health here.

Download
 

Research Report: Post-Exposure Prophylaxis (PEP)

The GPZL’s Research Agenda Working Group analyzed current research and developed priorities in several key areas that could accelerate progress towards zero leprosy. Download the report on post-exposure prophylaxis (PEP) here.

Download